Brief: Monopar Announces Abstract Accepted With Distinction For Oral And Poster Presentations At The Upcoming American Neurological Association 2025 Annual Meeting
03/09/2025 15:32
Sept 3 (Reuters) - Monopar Therapeutics Inc MNPR.O: MONOPAR ANNOUNCES ABSTRACT ACCEPTED WITH DISTINCTION FOR ORAL AND POSTER PRESENTATIONS AT THE UPCOMING AMERICAN NEUROLOGICAL ASSOCIATION 2025 ANNUAL MEETING Source text: ID:nGNX8ts4x8 Further company coverage: MNPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla